Royalty Pharma plc (RPRX)

Market Closed

17 Jul, 20:00

NASDAQ (NGS)

58. 18

-0.35

-0.598%

23.94B Market Cap

11.13 P/E Ratio

0.84% Div Yield

2.54M Volume

3.8 Eps

$ 58.53

Previous Close

Investors:

Analysts:

Day Range

58.12 59.44

Year Range

34.08 59.44

Want to track RPRX and more in your Portfolio? 🎯

Royalty Pharma plc Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Yuen Man Lee Persistent Asset Partners Ltd.	5,178	$200,077.79	$305,657.34	$105,579.55	52.77%
GLF Groupe La Francaise Groupe La Francaise	194	$9,306	$11,451.82	$2,145.82	23.06%
RFL Rossby Financial LLC Rossby Financial LLC	145	$5,415.88	$8,567.32	$3,151.44	58.19%
DWM Dogwood Wealth Management LLC Dogwood Wealth Management LLC	95	$4,590.38	$5,591.7	$1,001.32	21.81%
GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	9,596	$283,255.85	$564,820.56	$281,564.71	99.4%
Ameriflex Group Inc. Ameriflex Group Inc.	340	$11,995	$20,012.4	$8,017.4	66.84%
DR Don Ruffin Park Square Financial Group LLC	164	$7,867	$9,653.04	$1,786.04	22.7%
KGL Kilter Group LLC Kilter Group LLC	50	$1,802	$2,956.5	$1,154.5	64.07%
Asa Wallenberg Lansforsakringar Fondforvaltning AB (publ)	162,789	$4.55M	$9.58M	$5.03M	110.47%
Binnacle Investments Inc. Binnacle Investments Inc.	24	$847	$1,419.12	$572.12	67.55%
Nicole Reese WPG Advisers LLC	20	$622.6	$1,179.6	$557	89.46%
AAI ABN AMRO Investment Solutions ABN AMRO Investment Solutions	32,130	$1.54M	$1.81M	$267,964.3	17.39%